{"id":"https://openalex.org/W2808729681","doi":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","title":"Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008)","display_name":"Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008)","publication_year":2018,"publication_date":"2018-04-10","ids":{"openalex":"https://openalex.org/W2808729681","doi":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","mag":"2808729681"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.90.15_supplement.s23.008","doi":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001409814","display_name":"Bianca Santomasso","orcid":"https://orcid.org/0000-0001-9423-4059","observed_orcids":["https://orcid.org/0000-0001-9423-4059"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bianca Santomasso","raw_affiliation_strings":["Neurology, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100702718","display_name":"Jae Hong Park","orcid":"https://orcid.org/0000-0002-5274-7064","observed_orcids":["https://orcid.org/0000-0002-5274-7064"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae Hong Park","raw_affiliation_strings":["Medicine, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036831073","display_name":"Isabelle Rivi\u00e8re","orcid":"https://orcid.org/0000-0002-7363-3963","observed_orcids":["https://orcid.org/0000-0002-7363-3963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabelle Riviere","raw_affiliation_strings":["Sloan Kettering Institute New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan Kettering Institute New York NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103758939","display_name":"Elena Mead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Mead","raw_affiliation_strings":["Anesthesiology-Critical Care, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anesthesiology-Critical Care, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100714113","display_name":"Daniel Li","orcid":"https://orcid.org/0000-0003-4293-4509","observed_orcids":["https://orcid.org/0000-0003-4293-4509"]},"institutions":[{"id":"https://openalex.org/I4405280080","display_name":"Juno Therapeutics (United States)","ror":"https://ror.org/02dq5dx40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4405280080"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Li","raw_affiliation_strings":["Juno Therapeutics Seattle WA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Juno Therapeutics Seattle WA United States","institution_ids":["https://openalex.org/I4405280080"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062885345","display_name":"Brigitte S\u00e9n\u00e9chal","orcid":"https://orcid.org/0000-0003-2467-5152","observed_orcids":["https://orcid.org/0000-0003-2467-5152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brigitte Senechal","raw_affiliation_strings":["Sloan Kettering Institute New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan Kettering Institute New York NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011077747","display_name":"Terence J. Purdon","orcid":"https://orcid.org/0009-0009-7824-7760","observed_orcids":["https://orcid.org/0009-0009-7824-7760","https://orcid.org/0000-0002-2083-1667"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terrence Purdon","raw_affiliation_strings":["Sloan Kettering Institute New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan Kettering Institute New York NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077473098","display_name":"Elizabeth F. Halton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Halton","raw_affiliation_strings":["Nursing, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nursing, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033055418","display_name":"Claudia Diamonte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Diamonte","raw_affiliation_strings":["Nursing, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nursing, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059625599","display_name":"Michel Sadelain","orcid":"https://orcid.org/0000-0002-9031-8025","observed_orcids":["https://orcid.org/0000-0002-9031-8025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Sadelain","raw_affiliation_strings":["Sloan Kettering Institute New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan Kettering Institute New York NY United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085467141","display_name":"Renier Brenjens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renier Brenjens","raw_affiliation_strings":["Medicine, Memorial Sloan Kettering Cancer Center New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Memorial Sloan Kettering Cancer Center New York NY United States","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3673,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.62439492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"90","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8769999742507935},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/adult-leukemia","display_name":"adult leukemia","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.8027573823928833},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6831538677215576},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.6274502277374268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5874183177947998},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.5481460690498352},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.48240673542022705},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4444213807582855},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.42897239327430725},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4266689419746399},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.38914498686790466},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3665410280227661},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27558279037475586},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1449064016342163},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.1074131429195404},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.08145886659622192}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.90.15_supplement.s23.008","doi":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.s23.008","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889858763","https://openalex.org/W2805523469","https://openalex.org/W2784502872","https://openalex.org/W2890120543","https://openalex.org/W4224123414","https://openalex.org/W3120089265","https://openalex.org/W4408956713","https://openalex.org/W2985414343","https://openalex.org/W2917676884","https://openalex.org/W4220685620"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"describe":[2],"neurotoxicity":[3,35,163,222],"associated":[4,192],"with":[5,52,115,120,162,193,217,266,324,348,369,410,478,513],"19\u201328z":[6],"CAR":[7,60,127,145,272],"T":[8,17,61,128,146,198,267],"cell":[9,25,32,129,147,199,268],"therapy.":[10],"Background:":[11],"CD19-specific":[12],"chimeric":[13],"antigen":[14],"receptor":[15,113],"(CAR)":[16],"cells":[18,62],"are":[19],"highly":[20],"effective":[21],"for":[22,302,312,336,357,398,466,501],"relapsed/refractory":[23],"B":[24,31],"acute":[26,221],"lymphoblastic":[27],"leukemia":[28],"and":[29,73,102,125,143,171,208,232,260,271,275,283,296,299,327],"other":[30,322,346,367,408,476,511],"malignancies,":[33],"however":[34,154],"(NTX)":[36],"is":[37,244],"a":[38,66,224,316,340,361,402,470,505],"significant":[39,138],"treatment-related,":[40],"potentially":[41],"life-threatening":[42],"toxicity":[43],"that":[44],"remains":[45],"poorly":[46],"understood.":[47],"Design/Methods:":[48],"Fifty-three":[49],"adult":[50],"patients":[51,80,86,216],"B-ALL":[53],"received":[54,309,333,354,375,395,463,484,498,519,555],"lymphodepleting":[55],"chemotherapy":[56],"followed":[57],"by":[58,81,96,246],"19\u201329z":[59],"as":[63,433,549],"part":[64],"of":[65,183,197,214,227,286],"single-institution":[67],"phase":[68],"I":[69],"clinical":[70],"trial.":[71],"Clinical":[72],"research":[74,426,542,556],"parameters":[75],"were":[76,173,186],"analyzed":[77],"after":[78,108],"stratifying":[79],"NTX":[82,141,250,294],"grade.":[83],"Results:":[84],"Twenty-two":[85],"(41.5%)":[87],"developed":[88],"severe":[89],"(grade":[90],"3\u20134)":[91],"neurologic":[92,248],"complications":[93],"characterized":[94,245],"predominantly":[95],"aphasia,":[97],"encephalopathy,":[98],"depressed":[99],"consciousness,":[100],"myoclonus,":[101],"seizure.":[103],"Neurologic":[104],"symptoms":[105],"typically":[106],"resolved":[107],"steroids":[109],"but":[110],"not":[111],"IL-6":[112],"blockade":[114],"tocilizumab.":[116],"sNTX":[117,194],"was":[118,160,431,547],"correlated":[119,161],"pre-infusion":[121],"disease":[122],"burden":[123],"(p=0.013)":[124],"peak":[126],"expansion":[130],"in":[131,149,175,258,421,427,537,543],"the":[132,144,150,181],"blood":[133],"(p=0.0001).":[134],"We":[135],"found":[136],"no":[137],"correlation":[139],"between":[140],"grade":[142,164],"quantity":[148],"CSF":[151,176,276],"during":[152,220],"NTX,":[153],"cerebrospinal":[155],"fluid":[156],"(CSF)":[157],"protein":[158],"level":[159],"(p=0.0109).":[165],"The":[166],"cytokines":[167,190,270,288],"IL6,":[168],"IL8,":[169],"IP10":[170],"MCP1":[172],"elevated":[174],"relative":[177],"to":[178,390,440,446,452,458],"serum":[179,189],"at":[180,195],"time":[182],"NTX.":[184],"These":[185,291],"distinct":[187,253,287],"from":[188,254,289,383,492,527,558],"significantly":[191],"d3":[196],"infusion:":[200],"GMCSF,":[201],"IFN\u03b3,":[202],"IL15,":[203],"IL5,":[204],"IL10,":[205],"IL-6,":[206],"IL2,":[207],"IL3":[209],"(all":[210],"p":[211],"<0.01).":[212],"4":[213],"15":[215],"MRI":[218,274],"neuroimaging":[219],"had":[223],"shared":[225],"pattern":[226],"T2/FLAIR":[228],"changes":[229],"affecting":[230],"deep":[231],"brainstem":[233],"structures,":[234],"suggesting":[235],"transient":[236,279],"localized":[237],"vasogenic":[238],"edema":[239],"or":[240,321,345,366,379,407,475,488,510,523],"toxicity.":[241],"Conclusions:":[242],"Neurotoxicity":[243],"specific":[247],"symptoms.":[249],"can":[251],"be":[252],"cytokine":[255],"release":[256],"syndrome":[257],"timing":[259],"severity.":[261],"Blood":[262],"findings":[263,277,292],"suggest":[264,278],"association":[265],"activation":[269],"proliferation.":[273],"blood-CSF":[280],"barrier":[281],"breakdown":[282],"CNS-specific":[284],"production":[285],"blood.":[290],"inform":[293],"screening":[295],"management":[297],"algorithms":[298],"highlight":[300],"areas":[301],"future":[303],"study.":[304],"Disclosure:":[305],"Dr.":[306,330,351,372,386,392,414,429,436,442,448,454,460,481,495,516,530,545,552],"Santomasso":[307],"has":[308,332,353,374,388,394,438,444,450,456,462,483,497,518,554],"personal":[310,334,355,396,464,499],"compensation":[311,335,356,397,465,500],"consulting,":[313,337,358,399,467,502],"serving":[314,338,359,400,468,503],"on":[315,339,360,401,469,504],"scientific":[317,341,362,403,471,506],"advisory":[318,342,363,404,472,507],"board,":[319,343,364,405,473,508],"speaking,":[320,344,365,406,474,509],"activities":[323,347,368,409,477,512],"Juno":[325,349,370,384,411,422,479,493,514,528,538,559],"Therapeutics":[326,412],"Kite":[328],"Pharma.":[329],"Park":[331],"Therapeutics.":[350,371,385,480,494,515,529,560],"Riviere":[352,373],"royalty,":[376,485,520],"license":[377,486,521],"fees,":[378,487,522],"contractual":[380,489,524],"rights":[381,490,525],"payments":[382,491,526],"Mead":[387],"nothing":[389,439,445,451,457],"disclose.":[391,441,447,453,459],"Li":[393,415,430],"(employment).":[413],"holds":[416,532],"stock":[417,419,533,535],"and/or":[418,534],"options":[420,536],"Therapeutics,":[423,539],"which":[424,428,540,544],"sponsored":[425,541],"involved":[432,548],"an":[434,550],"investigator.":[435,551],"Senechal":[437],"Purdon":[443],"Halton":[449],"Diamonte":[455],"Sadelain":[461,482],"Brenjens":[496,517,531,546,553],"support":[557]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-29T00:00:00"}